TEVA Valuation

Teva Pharmaceutical Industries Ltd (TEVA) has a current Price-to-Book (P/B) ratio of 4.71. Compared to its 3-year average P/B ratio of 2.44 , the current P/B ratio is approximately 93.56% higher. Relative to its 5-year average P/B ratio of 1.88, the current P/B ratio is about 150.83% higher. Teva Pharmaceutical Industries Ltd (TEVA) has a Forward Free Cash Flow (FCF) yield of approximately 1.69%. Compared to its 3-year average FCF yield of 6.10%, the current FCF yield is approximately -72.29% lower. Relative to its 5-year average FCF yield of 4.81% , the current FCF yield is about -64.83% lower.